Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
08/2013
08/14/2013CN101691338B Synthesis method of chiral epoxy compound and intermediate products and final product
08/13/2013US8507724 Compounds for use in the treatment of pain
08/13/2013US8507723 Polycationic compounds and uses thereof
08/13/2013CA2724947C Low molecular weight pigment dispersants for phase change ink
08/13/2013CA2709871C Polymer precursors of radiolabeled compounds, and methods of making and using the same
08/13/2013CA2570041C Process for the preparation of nateglinide
08/08/2013WO2013049013A3 Preparation of bromomethylated derivatives via protection with trihaloacetic anhydride
08/08/2013US20130203738 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
08/08/2013US20130203727 Napht-2-ylacetic acid derivatives to treat aids
08/07/2013EP2622970A1 Salty taste enhancer
08/07/2013CN103232723A Easter compounds and preparation method thereof
08/07/2013CN103232409A Preparation method of disperse dyestuff
08/07/2013CN103232408A Disperse dye compound
08/07/2013CN103232359A Environmental-friendly nitrile hydrolysis method
08/07/2013CN103232358A Vesicle probe used for detecting neomycin, and application and preparation method thereof
08/07/2013CN103232357A Method for preparing alpha, beta-unsaturated amide
08/07/2013CN103232347A A brain targeting prodrug for CNS (central nervous system) drugs and a preparation method thereof, and applications of borneol in the brain targeting prodrug for CNS drugs
08/07/2013CN102503849B Synthetic method of N-(3-amino propyl)methacrylamide hydrochloride
08/07/2013CN101993418B (Methyl) acrylamido carboxylate ionic liquid and preparation method thereof
08/06/2013US8501994 Acetamide stereoisomer
08/06/2013US8501993 Processes for the preparation of amides
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/06/2013US8501814 Selective androgen receptor modulators
08/06/2013US8501813 γ-secretase inhibitor
08/06/2013US8501809 Inhibitors of α4 mediated cell adhesion
08/06/2013CA2648121C Preparation of chiral amides and amines
08/06/2013CA2629223C Glucagon receptor antagonists, preparation and therapeutic uses
08/01/2013WO2012113999A8 Process and intermediates for synthesizing agomelatine
08/01/2013US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof
08/01/2013US20130195782 Novel Glycine Derivative Capable Of Inhibiting Melanin Formation And Composition Using The Same
07/2013
07/31/2013CN103228665A Method for buffering chemical or biological composition
07/31/2013CN103228632A Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
07/31/2013CN103228621A Labeling agent and amino acid sequence using same, and method for performing simultaneous quantitative analysis of multiple proteins
07/31/2013CN103224260A Wastewater treatment and recovery method
07/31/2013CN102199098B New synthesis method and application of (R)-N-benzyl-1-(4-methoxyphenyl)-2-propylamine
07/31/2013CN102070480B Method for synthesizing taxol side chains
07/30/2013US8497271 Modulators of G protein-coupled receptor 88
07/25/2013WO2013078446A3 Derivatives of phenoxyisobutyric acid
07/25/2013US20130190407 Calcium receptor-active molecules
07/25/2013US20130190397 Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
07/25/2013US20130190371 Fungicide Active Substance Combinations
07/25/2013US20130190327 Bis-fatty acid conjugates and their uses
07/25/2013US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression
07/25/2013US20130189287 Enzymatic conjugation of polypeptides
07/24/2013EP2617707A1 Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
07/24/2013EP2617706A1 Novel intermediate used for preparing tapentadol or analogues thereof
07/24/2013EP2616444A2 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
07/24/2013EP2616430A2 Novel phenoxyisobutyric acid compounds and methods for synthesis
07/24/2013CN103221383A Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
07/24/2013CN103217523A Sugar chain-capturing substance and use thereof
07/24/2013CN103214736A Amides beta-crystal-form isotactic polypropylene nucleating agent as well as preparation method and application thereof
07/24/2013CN103214520A Ionic liquid covalent-loaded chiral phosphine ligand and application thereof
07/24/2013CN103214390A N-ethyl methylpropenyl dehydroabietic amide and synthesis method thereof
07/24/2013CN103214389A Application of N, N'-dual-fatty acyl group ethanediamine sodium malonate compounded system in tertiary oil recovery
07/24/2013CN103214388A Nitrated waste acid recycling method
07/24/2013CN103214387A Method for preparing N,N-diethylformamide
07/24/2013CN103214386A New method for synthesizing amide compounds
07/24/2013CN103214376A Substituted 4-aminocyclohexane derivatives
07/24/2013CN103214329A Preparation method of N-methylformamide catalyzed by metallic copper salt
07/24/2013CN103214326A Synthesis method of cinnamate, cinnamonitrile, cinnamamide and derivative thereof
07/24/2013CN103212415A A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
07/24/2013CN102137652B Use of an N-acyl amino acid selected from among N-palmitoyl alanine, N-palmitoyl glycine, N-palmitoyl isoleucine, and N-cocoyl alanine as an active agent controlling the proportion of basal keratinocytes of the human skin epidermis and expressing the nuclear form of surviving, and anti-aging cosmetic composition comprising same
07/24/2013CN101910125B Compounds from mycelium of antrodia cinnamomea and use thereof
07/24/2013CN101863794B 3'-alkoxy spirocyclische tetramic and tetronic acids
07/24/2013CN101538220B Method for splitting 3-acetamido-3-phenyl-methyl propionate enantiomer
07/24/2013CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof
07/24/2013CN101405258B N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
07/23/2013US8492593 Amido-fluorophosphite compounds and catalysts
07/23/2013US8492588 Benzyloxy anilide derivatives useful as potassium channel modulators
07/18/2013WO2013106238A1 Leukotriene b4 antagonist compound
07/18/2013WO2013104346A1 Lipopolyamines of spermine type for construction of liposomal transfection systems
07/18/2013US20130184345 Oligo-benzamide compounds for use in treating cancers
07/18/2013US20130184343 Insecticidal compounds
07/18/2013US20130184279 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
07/18/2013US20130183252 Compounds that inhibit (block) bitter taste in composition and methods of making same
07/18/2013CA2857521A1 Leukotriene b4 antagonist compound
07/17/2013EP2517700B1 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
07/17/2013CN103209969A Functionalised antifouling compounds and use thereof
07/17/2013CN103204784A Synthesis method for N-(3-aminopropyl) methacrylamide hydrochloride
07/17/2013CN102718985B Synthesis method of N, N'-ethylene bis stearamide-containing environment-friendly composite lubricant
07/17/2013CN102140166B Unsaturated polyether as well as preparation method and application thereof
07/17/2013CN101918355B Continuous method for producing amides of aromatic carboxylic acids
07/17/2013CN101918354B Continuous method for producing amides of ethylenically unsaturated carboxylic acids
07/16/2013US8487134 Process for the synthesis of amphetamine derivatives
07/16/2013US8487133 Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances
07/16/2013US8487131 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
07/16/2013US8487130 Menthylcarboxamides and their use as cooling agents
07/16/2013US8487109 Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
07/16/2013US8487007 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide
07/16/2013US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
07/16/2013US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
07/11/2013WO2013102626A1 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament
07/11/2013WO2013063679A9 Use of neu1 sialidase inhibitors in the treatment of cancer
07/11/2013WO2013059582A3 Small molecule inhibitors of histone deacteylases
07/11/2013WO2013054273A9 Process for the preparation of agomelatine
07/11/2013US20130178620 Processes for preparing 3-benzazepines
07/11/2013US20130178534 N-Nonanoylvanillylamine as an agent for reducing the appetite, as an agent for imparting a feeling of fullness and as a mood enhancer, and corresponding substance mixtures, orally consumable products and methods
07/10/2013EP2612847A1 Recording material using phenol compound
07/10/2013EP2612845A1 Aromatic compound containing specific branch
07/10/2013EP2611771A1 New compounds, pharmaceutical compositions and uses thereof
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 289